RHA REDENSITY
Live / Registered — Registered (as of 28 Jan 2025)
What this means for you
Registered since 28 Jan 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97166034
- Registration number
- 7671908
- Mark type
- Word mark
- Filed
- 10 Dec 2021
- Published for opposition
- 20 Jun 2023
- Registered
- 28 Jan 2025
- Attorney of record
- Bruce S. Londa
Goods and services
- Class 005 — Pharmaceuticals: sterile implantable products administered by injection for the filling of wrinkles, fine lines, skin depressions being injectable dermal fillers; dermatological pharmaceutical products injected into or under the skin, in or under the mucous membranes for the filling of wrinkles, skin depressions for remodeling, for increasing the volume of the face or any other part of the body, for hydration of the skin or mucous membranes, for increasing the volume of the lips; injectable dermal fillers; pharmaceutical agents for the epidermis
- Class 010 — Medical apparatus: medical syringes for the injection of dermatological products; fluid injectors for medical use; devices for the injection of pharmaceutical products; devices for the injection of pharmaceutical products
Owner
- TEOXANE S.A., Geneva, CH
- TEOXANE S.A., Geneva, CH
- TEOXANE S.A., Geneva, CH
Prosecution history
- 28 Jan 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 28 Jan 2025 — REGISTERED-PRINCIPAL REGISTER
- 07 Jan 2025 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 07 Jan 2025 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 02 Dec 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 02 Dec 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 02 Dec 2024 — TEAS REQUEST FOR RECONSIDERATION RECEIVED
- 17 Oct 2024 — NOTIFICATION OF FINAL REFUSAL EMAILED
- 17 Oct 2024 — FINAL REFUSAL E-MAILED
- 17 Oct 2024 — SU - FINAL REFUSAL - WRITTEN
- 17 Sept 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 17 Sept 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 17 Sept 2024 — ASSIGNED TO LIE
- 02 May 2024 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 23 Apr 2024 — NOTIFICATION OF NON-FINAL ACTION E-MAILED